Introduction {#s1}
============

The glucocorticoid receptor (GR) is a ligand (glucocorticoid)-activated transcription factor that participates widely in functions related to homeostasis and adaptation ([@bib16]). Functional properties of GR action have been widely queried, using pharmacological, viral vector and electrophysiological approaches, with most of the literature using rat models ([@bib24]; [@bib25]; [@bib13]; [@bib37]; [@bib42]). Recent decades have seen an increase in the use of mouse models to provide Cre-driver mediated deletion in specified cell populations (e.g. CaMKIIα neurons of the forebrain, Simpleminde-1 (Sim-1) neurons of the hypothalamus; [@bib29]; [@bib38]). While yielding valuable information on cell type-specific GR actions ([@bib36]), the use of mice has proven problematic with regard to high-resolution behavioral and physiological analyses due to the different behavioral repertoire of mice (high strain and inter-experiment variability in memory tests) and the small size (e.g., prohibits blood sampling of large volumes) ([@bib40]; [@bib30]; [@bib9]; [@bib7]).

The emergence of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)/Cas 9-mediated gene editing now affords gene targeting in numerous species, including rat ([@bib39]; [@bib35]; [@bib33]). For example, CRISPR/Cas9 methods allow for introduction of exon-flanking LoxP sites to generate conditional knockdown alleles and subsequent gene deletion following exposure to Cre recombinase using either driver lines or viral vector approaches. In this study, we used CRISPR/cas9 to specifically insert LoxP sites to sequences flanking exon 3 of the *Nr3c1* (*GR*) gene in Sprague Dawley rats (an outbred strain commonly used to explore GR function) via homology-directed repair (HDR). Our data provide validation of the *Nr3c1* gene editing in rats, and the use of viral vector-mediated Cre delivery to demonstrate targeting of GR knockdown to specific cell types, brain regions and circuits. Functional efficacy of GR knockdown in the prelimbic division (PL) of the medial prefrontal cortex (PL-PFC) was verified by sex-specific deficits in extinction of conditioned fear in females and a shift to active coping in the forced swim test (FST) in males. Overall, our study shows the utility of this gene editing technique to generate conditional gene deletion models that can leverage the considerable advantage of rats in behavioral and physiological research.

Results {#s2}
=======

We directly manipulated the genome of Sprague Dawley rat zygotes by CRISPR/Cas9 to generate the floxed *Nr3c1* allele. We used a dual sgRNA strategy to delete the sequence containing exon 3 of the *Nr3c1* gene and repaired it with a cutting resistant donor plasmid that contains the deleted sequence, two flanking LoxP sites at the cut location of the sgRNA recognition sites, a right homologous arm at 2.57 kb, and a left homologous arm at 1.95 kb ([Figure 1A and B](#fig1){ref-type="fig"}). Because truncated sgRNAs increase targeting specificity ([@bib11]), we chose six sgRNAs with various lengths (17--20 nt) ([Appendix 1---table 1](#app1table1){ref-type="table"}) and validated their editing activity in rat C6 glioma cells by T7E1 assay ([Appendix 1---figure 1](#app1fig1){ref-type="fig"}). We picked two sgRNAs, sg-2 and sg-6, for targeting the 5' and 3' sequences of exon 3, respectively. Both sgRNAs were 17nt in length, which is expected to provide high specificity ([@bib11]). The two selected sgRNAs, Cas9 mRNA, and the donor plasmid were microinjected into \~60 rat zygotes, followed by embryo transfer into pseudopregnant female rats. Seventeen pups were born. We identified that one of them (No. \#60) was correctly targeted, which was confirmed by PCR with the external primers ([Figure 1C and D](#fig1){ref-type="fig"}) paired with the primers partially containing LoxP sequences (P5-P6 and P10-P8 for 5' and 3' ends, respectively; [Figure 1E and F](#fig1){ref-type="fig"}). It was further confirmed by primer pairs P5-P7 and P9-P8, followed by ClaI and BamHI enzyme digestion and Sanger sequencing (data not shown), and by additional Sanger sequencing of the entire targeted area between P5 and P8. This allele contains an A/T base change at chr18:31,744,353, compared to the rn6 reference genome, which is located in a non-conserved intronic region and unlikely to be of functional consequence. We verified copy number and used plasmid backbone PCR to exclude the possibility of random integration of the donor plasmid ([Appendix 1---figure 2](#app1fig2){ref-type="fig"}). We have consistently bred the offspring of rat \#60 to homozygosity ([Figure 1G](#fig1){ref-type="fig"}).

![Generation of *Nr3c1* conditional knockdown rat.\
(**A**) Schematic illustration of the targeting strategy. Two LoxP sequences flanking exon three were inserted via CRISPR/Cas9-mediated deletion by two sgRNAs, followed by homology-directed repair with a donor plasmid. The CRISPR reagents were injected into the cytoplasm of rat zygotes, followed by embryo transfer into surrogate mothers for fetal development and birth. Correctly targeted rats were bred to homozygosity. Deletion of exon three is achieved by recombination of two LoxP sequences upon the exposure of Cre recombinase. (**B**) The donor plasmid contains two LoxP sequences flanking exon 3, restriction enzyme sites, and two homologous arms. The LoxP sequence is located at the sgRNA cut site (three nucleotides prior to the PAM) to block re-cutting. (**C**) Primers used to confirm the correctly targeted events are listed in the boxes. (**D**) Primers P5 and P8 are external to homologous arms. (**E--G**) Sample PCR results are shown.](elife-44672-fig1){#fig1}

Validation of conditional GR knockdown: Viral vector targeting {#s2-1}
--------------------------------------------------------------

To test the efficacy of this novel rat line, we administered adenoviral Cre recombinase constructs to drive regional, cell type-specific and projection-specific knockdown of GR. Regional knockdown targeted the basolateral amygdala (BLA), using human synapsin promoter-driven Cre recombinase (AAV8-hSyn-Cre, UNC Vector Core, NC, USA) microinjections. Cre^+^ cells were devoid of nuclear GR immunoreactivity in SD:nr3c1^fl/fl^ rats ([Figure 2A](#fig2){ref-type="fig"}), whereas the vast majority of Cre^+^ cells co-expressed GR in wildtype controls (SD:nr3c1^wt^) ([Figure 2B](#fig2){ref-type="fig"}) injected with the same viral construct (AAV8-hSyn-Cre, UNC Vector Core).

![Viral validation of conditional glucocorticoid receptor (GR) knockdown rat.\
(**A**) AAV8-hSyn-Cre administration to the basolateral amygdala (BLA) in SD:nr3c1^fl/fl^ rats (panel A1- site of injection, 4X). Note the absence of GR (purple) in Cre^+^ neurons (green) (panels A2-4, 40x, yellow triangles). (**B**) AAV8-hSyn-Cre administration to the BLA in SD:nr3c1^wt^ rats (panel B1- site of injection, 4X). Note the presence of GR (purple) in Cre^+^ neurons (green) (panels B2-4, 40x, white triangles). (**C**) AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 (CaMKIIα Cre) injected into SD:nr3c1^f/f^ rats results in decreased GR (C4 yellow arrows) in cells infected with virus as shown by GFP labeling (C2 yellow arrows) that are also CaMKIIα positive (C3 yellow arrows). CaMKIIα cells not infected with GFP, show endogenous GR expression (C1-4 white arrows). (**D**) CaMKIIα Cre injected into SD:nr3c1^wt^ rats (panel C2-4 40x white arrows) shows endogenous GR staining (D4) in cells infected with virus shown in GFP (D2) and CaMKIIα positive (D3). (**E**) AAVrg-pmSyn1-EBFP-Cre administration to the BLA in SD:nr3c1^fl/fl^ rats (panel E-1 site of injection, 4X) and retrograde trafficking of the virus to cell somas in the prefrontal cortex (PFC) (panel E2-4). Note absence of GR expression (purple) in Cre^+^ neurons (green) (panel E5-7, 20x, yellow triangles). (**F**) AAVrg-CAG-GFP administration to the BLA in SD:nr3c1^fl/fl^ rats (panel F1- site of injection, 4X) and retrograde trafficking of the virus to cell somas in the PFC (panel F2-4, 10X). Note expression of GR (purple) in GFP^+^ neurons (green) (panel F5-7, 20x, white triangles).](elife-44672-fig2){#fig2}

We then assessed cell-type specific knockdown by injection of AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 (CaMKIIα Cre) virus into the PFC of SD:nr3c1^wt^ or SD:nr3c1^fl/fl^ rats. Infusions of CaMKIIα Cre caused widespread loss of GR immunoreactivity within GFP^+^cells in the PFC of CaMKIIα Cre virus injected SD:nr3c1^fl/fl^ rats ([Figure 2C](#fig2){ref-type="fig"} yellow arrows), but no GR loss is noted in wildtype control (SD:nr3c1^wt^) injected rats ([Figure 2D](#fig2){ref-type="fig"} white arrows) or in uninfected CaMKIIα cells in SD:nr3c1^fl/fl^ rats ([Figure 2C](#fig2){ref-type="fig"} white arrows).

Finally, we used an intersectional approach to examine connectional knockdown of GR, focusing on PFC projection neurons to the BLA. Retrogradely-infected (Cre^+^) neurons were observed in the PFC after administration of AAVrg pmSyn1-EBFP-Cre, (Addgene) to the BLA. We did not observe GR immunoreactivity in SD:nr3c1^fl/fl^ rats ([Figure 2E](#fig2){ref-type="fig"}), whereas substantial proportions of PFC-BLA projecting neurons contained GR immunoreactivity in control virus (AAVrg-CAG-GFP, Addgene) injected animals ([Figure 2F](#fig2){ref-type="fig"}). Although we made every effort to employ appropriate viral controls, we were limited by the availability of viral constructs, specifically AAV retrograde constructs, and this is a caveat of the current study. For our intersectional approach we used the same AAV serotype (AAVrg) for both knockdown and controls however, the promoter (pmSyn1 vs CAG) and fluorescent reporter (EBFP vs GFP) were different. These constructs were chosen as the best available at the time of running the experiments. These studies highlight the novel use of this rat model to query not only the role of GR in a specific region in isolation but also how GR functions as part of an integrated circuit.

Behavioral consequences of targeted GR knockdown; Implications for fear and coping behaviors {#s2-2}
--------------------------------------------------------------------------------------------

We next performed a functional test of viral Cre-mediated GR knockdown, focusing on the PL-PFC. SD:nr3c1^fl/fl^ (GRKD) rats and wild type littermate controls SD:nr3c1^wt^ (Control) all received injection of AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 (CaMKIIα Cre) \[Penn Vector Core\] into the PL-PFC [Figure 3E](#fig3){ref-type="fig"}. CaMKIIα is a calcium binding protein that is most commonly found in glutamatergic neurons of the forebrain (although there is evidence of the presence of CaMKIIα in some GABAergic interneurons in the amygdala and striatum and possibly the PFC; [@bib17]; [@bib19]; [@bib34]), thus we are targeting a glutamatergic enriched populations of neurons in the PL-PFC.

![Verification of glucocorticoid receptor (GR) knockdown in the prelimbic division of the prefrontal cortex (PL-PFC).\
(**A**) Female SD:nr3c1^fl/fl^ rats injected with AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 show reduced GR expression in virus infected neurons (GFP^+^) compared to controls (\*\*\*\*p\<0.0001, unpaired t-test, GRKD = SD:nr3c1^fl/fl^ plus CaMKIIα Cre, n = 5; Control = SD:nr3c1^wt^ plus CaMKIIα Cre, n = 10). (**B**) Male SD:nr3c1^fl/fl^ rats injected with AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 show reduced GR expression in virus infected neurons (GFP^+^) compared to controls (\*\*\*\*p\<0.0001, unpaired t-test, GRKD = SD:nr3c1^fl/fl^ plus CaMKIIα Cre, n = 6; Control = SD:nr3c1^wt^ plus CaMKIIα Cre, n = 9). (**C**) Representative image of GR expression in GFP+ neurons in the area of infection (PL-PFC) in a SD:nr3c1^wt^ rat. Green = viral infected neurons, Red = GR, yellow = GFP cell outline. (**D**) Representative image of GR knockdown in GFP+ neurons in the area of infection (PL-PFC) in a SD:nr3c1^fl/fl^ rat injected with AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40. Green = viral infected neurons, Red = GR, yellow = GFP cell outline. (**E**) Representative image of CaMKIIα injection site and area of infection in the PL-PFC. Red = Cre recombinase protein.](elife-44672-fig3){#fig3}

We first confirmed GR knockdown in virus infected neurons in both females and males using immunohistochemistry \[Females = T(13)=9.752; p\<0.0001 ([Figure 3A](#fig3){ref-type="fig"})\]; \[Males = T(13)=6.202; p\<0.0001 ([Figure 3B](#fig3){ref-type="fig"})\].

The PFC plays a critical role in extinction of emotional memory (e.g. conditioned fear), selection of emotional coping strategy, and hypothalamic pituitary adrenal (HPA) axis reactivity ([@bib1]; [@bib14]; [@bib31]; [@bib32]). We therefore tested whether GR knockdown in CaMKIIα targeted neurons in this region affected extinction of conditioned fear to an auditory fear conditioning paradigm, and behavioral coping during the FST. For fear conditioning, rats were exposed to five tone shock pairings on the first day (acquisition), followed by 2 days of 20 tones without a paired shock, (extinction and extinction recall). Data was binned for clarity into five tones per bin. Freezing during the tones was measured as fear behavior. Freezing in female rats with PL-PFC targeted GRKD (SD:nr3c1^fl/fl^ plus CaMKIIα Cre) increased in acquisition \[GRKD F(1,52) = 5.553; p=0.035\], but there was no significant interaction effect \[GRKD x tone F(4,52) = 1.292; p=0.285\] ([Figure 4A](#fig4){ref-type="fig"}). Extinction of fear conditioning was delayed in the female GRKD group relative to controls, as indicated by a significant time x GRKD interaction effect \[GRKD x time F(3,39) = 4.184; p=0.012\] ([Figure 4A](#fig4){ref-type="fig"}). Extinction recall was also impaired in female PL-PFC GRKD rats relative to controls (significant time x GRKD interaction) \[GRKD x time F (3,31)=3.796; p=0.020\] ([Figure 4A](#fig4){ref-type="fig"}). Meanwhile, males with PL-PFC targeted GRKD (SD:nr3c1^fl/fl^ plus CaMKIIα Cre) did not differ from controls \[Acquisition GRKD x tone F(1,79\]=1.827; p=0.136\] \[Extinction GRKD x tone F(1,63) = 0.873; p=0.463\] \[Extinction Recall GRKD x tone F(1,63) = 0.592; p=0.624\] ([Figure 4B](#fig4){ref-type="fig"}). While most lesion and inactivation studies have shown that the PL-PFC is critical for appropriate fear responding ([@bib14]; [@bib31]; [@bib32]), the use of the GR floxed rat model has shown that GR in the CaMKIIα neurons of the PL-PFC may be more critical for female expression and extinction of conditioned fear, and less so for males.

![Behavioral profile of glucocorticoid receptor (GR) knockdown in CaMKIIα cells in the prelimbic division of the prefrontal cortex (PL-PFC).\
(**A**) Female rats with PL-PFC CaMKIIα GRKD showed heightened freezing to tone shock pairings compared to controls, as well as deficits in fear extinction, and heightened freezing during extinction retrieval indicating an inability to extinguish conditioned fear (\*=p \< 0.05 with Bonferroni posthoc). (**B**) Male rats with PL-PFC CaMKIIα GRKD did not differ from controls during auditory fear conditioning. (**C--D**) Male rats with CaMKIIα GRKD in the PL-PFC did not show differences from controls in immobility on either day in the forced swim test, (**E--F**), but PL-PFC CaMKIIα GRKD male rats did show a greater number of dives on both days suggesting a more active coping behavior (\*=p \< 0.05 Student\'s two-tailed T-test). (**G--J**) Female rats with PL-PFC CaMKIIα GRKD did not show differences from controls in the forced swim test. (**K**) Females with PL-PFC CaMKIIα GRKD show a significant GRKD x time interaction in corticosterone after acute restraint as well as higher corticosterone at the 120 min time point (p=0.050 with Bonferroni posthoc). (**L**) Male rats with PL-PFC CaMKIIα GR knockdown do not show differences from control in corticosterone release to acute restraint. (GRKD = SD:nr3c1^fl/fl^ plus AAV CaMKIIα Cre, n = 5--6 male and female; Control = SD:nr3c1^wt^ plus AAV CaMKIIα Cre, n = 10 male and female).](elife-44672-fig4){#fig4}

The PFC has also been implicated in coping behaviors and behavioral adaptation during acute and chronic stress. We used the FST to investigate remodeling of behavioral coping strategy during an acute stress challenge. There was no effect of PL-PFC-driven GRKD (SD:nr3c1^fl/fl^ plus CaMKIIα Cre) on immobility time in the FST on either day 1 or day 2 for male rats \[Day 1 immobility T(14) = −1.8.48; p=0.085\] ([Figure 4C](#fig4){ref-type="fig"}) \[Day 2 immobility T(14) = −1.411; p=0.180\] ([Figure 4D](#fig4){ref-type="fig"}). However, males with CaMKIIα-driven PL-PFC GRKD (SD:nr3c1^fl/fl^ plus CaMKIIα Cre) increased diving frequency on day 1 \[T(14)=3.252; p=0.005\] ([Figure 4E](#fig4){ref-type="fig"}) relative to controls, consistent with an altered coping strategy. This behavior persisted into the second day of the FST test, with significantly higher number of dives for males with PL-PFC GRKD (SD:nr3c1^fl/fl^ plus CaMKIIα Cre) \[T(14) = - 3.468; p=0.003\] ([Figure 4F](#fig4){ref-type="fig"}). Females with PL-PFC GRKD (SD:nr3c1^fl/fl^ plus CaMKIIα Cre) did not differ from controls in total immobility ([Figure 4G--H](#fig4){ref-type="fig"}) or number of dives ([Figure 4I--J](#fig4){ref-type="fig"}) \[Day 1 Immobility, T(13) = 0.077; p=0.939\] \[Day 2 immobility, T(13) = −1.083; p=0.298\] \[Day 1 dives, T(13) = −0.187; p=0.854\] \[Day 2 dives, T(13) = −1.316; p=0.211\]. Although there were no changes in total immobility in the FST, increased diving in the males with PL-PFC GRKD suggests GR in CaMKIIα neurons of the PL-PFC may facilitate a shift, selectively in males, to more diverse active escape behaviors than just swimming and climbing alone.

Our lab has previously shown that GRKD in the PL-PFC increases corticosterone to acute restraint ([@bib24]). We subjected male and female GRKD and control rats to a 30min acute restraint challenge and took tail blood samples at 0 min, 15 min, 30 min, 60 min, and 120 min from the start of restraint to measure plasma corticosterone. There was a GRKD x time interaction \[F(4,45)=3.020; p=0.027\] in females, with post hoc analysis revealing delayed shut-off (120 min time point) of the HPA axis stress response in PL-PFC-GRKD rats \[p=0.050\] ([Figure 4K](#fig4){ref-type="fig"}). There was no effect of GRKD \[F(1,44)=2.046; p=0.180\] or GRKD x time interaction observed in males \[F(4,44)=0.935; p=0.452\] ([Figure 4L](#fig4){ref-type="fig"}). The data suggest that female SD:nr3c1^fl/fl^ rats with PL-PFC GRKD may have deficits in negative feedback inhibition due to the inability to return to a similar resting level of corticosterone as control rats. The lack of differences after PL-PFC GRKD in the males compared to our previous study may be due to the specificity of our virus to knockdown primarily in CaMKIIα cells, whereas previously a ubiquitous promotor on a lentiviral delivered shRNA was used which targets all neuronal cell types, including inhibitory GABAergic interneurons ([@bib24]).

Discussion {#s3}
==========

Prior studies document generation of knockdown and Cre dependent knockdown rat models using CRISPR/Cas9 as a molecular tool ([@bib35]; [@bib21]) reviewed in [@bib39]. Here we created a conditional (Cre-recombinase dependent) GR knockdown rat using CRISPR/Cas9. Validation of genome integration was accomplished by PCR, and Cre-dependent knockdown by site and circuit specific viral vector expression of Cre-recombinase. Finally, efficacy and consequences of GR knockdown in the PL-PFC were supported by sex-specific effects in behavior. The CaMKIIα promoter is thought to largely direct Cre expression to cortical projection neurons with over 80% specificity and efficacy ([@bib41]) and thus it is likely our manipulations were able to successfully target a cell population composed mostly of excitatory projection neurons.

Deficits in fear conditioning and alterations in behavioral coping style are a common phenotype in murine GR knockdown models as well as following chronic stress ([@bib24]). We used site and cell specific knockdown of GR to demonstrate that CaMKIIα cells in the PL-PFC require GR for appropriate fear responses and extinction in females. Conversely, male rats lacking GR in the PL-PFC, shift to an active escape behavior in the FST, suggesting adoption of an active coping strategy. Females (but not males) evidenced deficient shut-off of the HPA axis stress response, consistent with a sex-specific dependence of PL-PFC GR for full feedback inhibition. The data highlight a strong interaction between GR signaling and sex in coordination of prefrontal cortical signaling mechanisms. Moreover, the data provide functional evidence that CRISPR/Cas9 can be used to provide high-resolution cell and site specific assessment of GR action in brain, leveraging the advantages of the rat as a model organism.

Prior studies have used promoter-specific Cre driver mouse lines to generate targeted GR knockdown in mice. Mouse studies demonstrated that CaMKIIα-Cre directed GR deletion in the forebrain (targeting exon 2 or 3) promoted anxiety-related behavior, passive coping, and corticosterone hypersecretion in male, but not female mice ([@bib36]; [@bib3]; [@bib15]). It is important to note that the mouse CaMKIIα driver line deletes GR in multiple brain regions, including cortex, hippocampus, BLA, caudate, and bed nucleus of the stria terminalis, many of which interface with stress and emotional behavior. The extensive knockdown makes it impossible to specify circuit-specific roles of stress hormone signaling in behavior and stress physiology. Prior studies have not specified GR-specific deficits in cognitive behaviors, which can be difficult to assess in mouse models ([@bib40]; [@bib30]; [@bib9]). Here, we show that by using these viral constructs with specific promoters (CaMKIIα) in GR floxed rats, we can not only drive expression of Cre-recombinase in a cell-type specific manner, but also a defined region, allowing precise investigation of the role of GR in behavior.

There is a possibility of genetic modifications, even with the highly site specific editing of the CRISPR/Cas9 system, when inserting LoxP sites into the genome (reviewed in [@bib43]; [@bib10]; [@bib6]). We tested the most likely frameshift insertion and deletion (indel) mutations that could be introduced by unexpected non-homologous end joining or inaccuracies in the sgRNA targeting. We used PCR amplification and sequencing to determine that there were no mismatches in these sequences compared to wildtype controls ([Appendix 1---table 2](#app1table2){ref-type="table"} and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). We are thus confident that our LoxP insertion did not cause any genetic mutations that would interfere with in vivo studying of the GR functioning in the rats on a genetic basis. As an additional control, we further investigated physiological and behavioral effects of this targeted insertion. We performed multiple tests of behavior (open field, elevated plus maze, and FST), and observed no effect of gene targeting on any behavioral endpoint ([Appendix 1---figure 3](#app1fig3){ref-type="fig"}). Furthermore, we found no differences in bodyweight ([Appendix 1---figure 4](#app1fig4){ref-type="fig"}) or organ weights commonly changed with chronic stress ([Appendix 1---table 3](#app1table3){ref-type="table"}).

Our functional studies indicate that female (but not male) rats with knockdown of GR in the PL-PFC have heightened fear response and impaired extinction. Importantly, these data inform prior PL-PFC lesion/inactivation studies, which indicate that the PL-PFC is critical for appropriate encoding and expression of conditioned fear ([@bib31]; [@bib28]; [@bib23]). The data indicate that GR signaling is an important component of this process in females, but may be less so in males (although the increased freeze times in males may reflect a more 'intense' response to the shock, which may result in ceiling effects on subsequent exposure to cues). In the FST, males but not females increased the number of diving events. As diving is considered an active coping behavior ([@bib2]; [@bib12]; [@bib27]), it is likely that GR in the PL-PFC also interfaces with coping behaviors in a sex-specific manner. In combination, these data indicate that use of enhanced precision methods of gene targeting such as CRISPR/Cas9 in rat reveal substantive new information on the biology of the PL-PFC and its interaction with biological sex.

Deficits in conditioned fear and glucocorticoid feedback efficacy are associated with depression, post-traumatic stress disorder and other stress related diseases in human. It is important to consider that these disease states are overrepresented in women ([@bib24]; [@bib16]), and also involve modification of prefrontal cortical circuitry in neuroimaging studies ([@bib4]; [@bib5]; [@bib18]; [@bib26]). Emergence of behavioral deficits following targeting of GR in the PL-PFC of females may reflect a mechanism underlying selective vulnerability of females to stressful life events, suggesting that appropriate GR signaling is required to mitigate the impact of adversity.

Overall, we demonstrate that CRISPR/Cas9 gene editing is effective in generating novel tools for bio-behavioral research in a highly tractable model organism with a long and well-documented history. As noted in our functional studies, the SD:nr3c1^fl/fl^ line can be of significant value in the context of higher order behavioral assays (cognitive behaviors, goal-directed behaviors, reward behaviors/drug self-administration) that can be often difficult to implement and/or interpret in other rodent organisms, such as mice. With the growing number of viral Cre constructs and the recent surge in development of rat Cre driver lines, the CRISPR/Cas9 method can provide site and cell type gene deletions or manipulations that are vital for our understanding of mechanisms of stress pathologies and stress-related diseases.

Materials and methods {#s4}
=====================

Generation of the floxed *Nr3c1* line {#s4-1}
-------------------------------------

Six sgRNAs targeting the sequences flanking exon 3 of *Nr3c1* were designed using the CRISPR Design Tool website (<http://www.genome-engineering.org/>). The complementary oligos (IDT) with overhangs were cloned into the BbsI site of the pX459 vector (Addgene \#48139), according to the published methods ([@bib33]). Editing activity was validated by the T7E1 assay (NEB) in rat C6 glioma cells (ATCC), compared side-by-side with *ApoE* sgRNA that was previously shown to work efficiently in rat zygotes ([@bib21]). Validated sgRNA were in vitro transcribed by MEGAshorscript T7 kit and then purified by MegaClear kit (ThermoFisher). *Cas9* mRNA was in vitro transcribed by mMESSAGE mMACHINE T7 ULTRA kit (ThermoFisher), according to manufacturer's instructions. Two sgRNAs (50 ng/ul ech), *Cas9* mRNA (100 ng/ul), and the donor plasmid (100 ng/ul) were mixed in 0.1X TE buffer and injected into the cytoplasm of one-cell-stage embryos of Sprague Dawley genetic background rats via a piezo-driven cytoplasmic microinjection technique. Injected embryos were immediately transferred into the oviductal ampulla of pseudopregnant females. Live born pups were genotyped by PCR, enzyme digestion, and Sanger sequencing. Rats were bred and housed in a vivarium with a 12 hr light/dark cycle. All animal studies were approved by the Institutional Animal Care and Use Committees of the Cincinnati Children's Hospital Medical Center and University of Cincinnati.

Breeding and genotyping {#s4-2}
-----------------------

A female Sprague Dawley rat (\#60) containing the floxed *Nr3c1* alleles was generated by the Transgenic Animal and Genome Editing Core Facility ([Figure 1A and B](#fig1){ref-type="fig"}). The founder rat that was heterozygous for the LoxP knock-in sequences was crossed with a wildtype Sprague Dawley male rat. F1 heterozygous offspring were bred to generate F2 and F3 offspring. We used F2 and F3 heterozygote animals to generate SD:nr3c1^fl/fl^ and SD:nr3c1^wt^ littermate controls for behavioral and molecular experiments. Our breeding scheme was designed to minimize inbreeding by avoiding sibling x sibling mating.

We used four different sets of primers ([Figure 1C and D](#fig1){ref-type="fig"}) to verify that the LoxP sequences were inserted in the 5' and 3' sides of exon 3. DNA was extracted from tail blood sample by using PureLink Genomic DNA Kits (Invitrogen Cat \#: K1820-01, K1820-02, K1821-04). To discriminate the genotype of the rats, we performed PCR reactions with the primers that are listed in [Figure 1C and D](#fig1){ref-type="fig"}, by using FailSafe PCR 2X PreMix D (Epicenter Cat \# FSP995D) and Dream Taq enzyme (Thermofisher Cat \# EP0701) in a PTC-200 Peltier Thermal Cycler. All of the PCR products were analyzed with agarose gel electrophoresis and the images were captured by Axygen Gel Documentation System ([Figure 1E--G](#fig1){ref-type="fig"}).

For confirmation by sequencing, the expected bands from homozygote rats (SD:nr3c1^fl/fl^) and wildtype littermate controls (SD:nr3c1^wt^) were separated from the agarose gel and purified with Thermo Scientific GeneJET Gel Extraction Kit. The purified DNA was sent to Cincinnati Children's Hospital Medical Center (CCHMC) DNA Sequencing and Genotyping Core to sequence the 3' and 5' sites of exon 3 of the *Nr3c1* gene, using the P1-P2 and P3-P4 primers. The sequencing data clearly showed the inserted flox sequences in both 3' and 5' sides of *Nr3c1* in SD:nr3c1^fl/fl^ rats. The flox sequences were not seen in the SD:nr3c1^wt^ controls ([Figure 1G](#fig1){ref-type="fig"}).

Stereotaxic surgery {#s4-3}
-------------------

Adult male and female SD:nr3c1^fl/fl^ and SD:nr3c1^wt^ rats (250-350 g) were singly housed on a 12 hr light/dark cycle in a temperature- and humidity-controlled housing facility at the University of Cincinnati. All experimental procedures were conducted in accordance with the National Institutes of Health Guidelines for the Care and Use of Animals and were approved by the University of Cincinnati Institutional Animal Care and Use Committee. Animals were deeply anaesthetized with 4--5% Isoflurane, prior to placement in the stereotaxic frame (Kopf Instruments) and sedation maintained at 2--3% isoflurane during surgery. A 2 ul Hamilton syringe was used to administer viral constructs. The needle was gently lowered to the predefined coordinates for BLA (AP: −2.7, ML:±4.8, DV: 8.8) or PL-PFC (AP:+3.0, ML:±0.6, DV:−3.3) and a 5 min rest period was observed. The virus was infused over 5 min (1 ul/5mins). After infusion the needle remained in place for an additional 5 min. The needle was slowly removed and the hole sealed with gelfoam. After completion of all infusions, the surgical site was closed with surgical staples and animals were singly housed for recovery and for the remainder of the studies.

Viral constructs {#s4-4}
----------------

AAV8-hSyn-Cre (titer: 6.5 × 10¹² molecules/ml) was sourced from the UNC Vector Core (Chapel Hill, NC, USA). AAVrg-CAG-GFP (titer: 5 × 10¹² vg/mL, this construct was a gift from Edward Boyden to Addgene- viral prep \# 37825-AAVrg) and AAVrg pmSyn1-EBFP-Cre (titer: 6 × 10¹² vg/mL, this construct was a gift from Hongkui Zeng to Addgene -viral prep \# 51507-AAVrg; [@bib22]), were sourced from Addgene (MA, USA). All constructs were administered 1 ul bilaterally and a minimum of 3 weeks incubation was allowed.

For CaMKIIα cell-specific knockdown and fear conditioning and forced swim studies, 0.1 ul of AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 (CaMKIIα Cre) \[Penn Vector Core\] (titer: 6.544 × 10^13^ diluted to 6.544 × 10^11^\] was injected bilaterally and allowed 5 weeks to incubate.

Immunohistochemistry {#s4-5}
--------------------

3--5 weeks after viral injection animals were injected with an overdose of pentobarbital and perfused transcardially with 0.1M PBS until blood was clear, followed by 4% paraformaldehyde/0.1M PBS for 15 min. The brains were postfixed overnight at 4°C in 4% paraformaldehyde/0.1M PBS, rinsed 2 × 3 times with 0.1M PBS and cryoprotected in 0.1M PBS containing 30% sucrose + 0.01% sodium azide at 4°C until the brains sank in the sucrose solution. Brains were frozen to −20°C on the stage of a sliding microtome (Leica Biosystems Inc, Nußloch, Germany) and sectioned at 35 µm, collected in a series of 6 and placed in cryoprotectant consisting of 10% polyvinyl-pyrrolidone- Mol Wt 40,000,+500 ml of 0.1M PBS + 300 ml of ethylene glycol +30% sucrose and 0.01% sodium azide. A full series of 6 sections was labeled for GFP, GR and Cre Recombinase. For viral verification of AAV8-hSyn-Cre ([Figure 2A--B](#fig2){ref-type="fig"}), AAVrg pmSyn1-EBFP-Cre ([Figure 2E](#fig2){ref-type="fig"}), and AAVrg-CAG-GFP ([Figure 2F](#fig2){ref-type="fig"}), the sections were processed as follows: incubtaed with 1% sodium borohyhdride/0.1M PBS for 30 min, rinsed 6 × 5 min in 0.1M PBS, incubated with 1% hydrogen peroxide/0.1M PBS for10 min, rinsed 6 × 5 minin 0.1M PBS, rinsed additionally in 0.1M PBS 4 × 15 min. Sections were blocked by incubation 0.1M PBS containing 4% goat serum with 0.4% Triton X-100% and 0.2% BSA for 2 hr, followed by a cocktail including polyclonal rabbit GR antibody (Santa Cruz-Cat\# sc 1004) diluted 1:500, monoclonal mouse Cre Recombinase antibody (Millipore Cat \# MAB 3120) diluted 1:1000 and no GFP antibody label (native virus expression) in blocking solution consisting of 0.1M PBS containing 4% goat serum with 0.4% Triton X-100% and 0.2% BSA overnight at room temperature. After overnight antibody incubation, sections were rinsed in 0.1M PBS 3 × 5 min, then incubated in a cocktail of goat-anti-mouse CY3 conjugated IgG (Invitrogen-Cat\#A32727) diluted 1:800 and goat anti rabbit CY5 conjugated IgG (Invitrogen-Cat \# A32733) diluted 1:800 in 0.1M PBS for 45 min, and rinsed 4 × 5 min in 0.1M PBS. All sections were mounted and viewed on a Nikon C2 Plus Confocal Microscope.

For AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40 (CaMKIIα Cre) ([Figure 2C--2D](#fig2){ref-type="fig"}) cell-specific knockdown, brains were processed the same until immunohistochemistry. The sections were processed as followed: slices rinsed 5 × 5 in 0.1M PBS, incubation in 1.5% 10 mM Trisodium Citrate in PBS at 80°C for 10 min, rinsed 5 × 5 00.1M PBS, blocked in 0.2% BSA +4% goat serum 1 hr room temperature, and then incubated overnight at 4ºC in a cocktail of block plus rabbit polyclonal GR antibody (Invitrogen-Cat\# PA1-511A) diluted 1:800, chicken polyclonal GFP antibody (abcam-Cat\# ab13970) diluted 1:2000, and mouse monoclonal CaMKII antibody (abcam-Cat\# ab22609) diluted 1:250. The following day sections were washed 5 × 5 in 0.1M PBS and incubated at room temperature for 1 hr in the following secondary antibodies diluted 1:500 in blocking solution: goat-anti-Rabbit Cy3 conjugated IgG (Invitrogen-Cat\# A10520), goat-anti-chicken conjugated Alexa 488 (Invitrogen-Cat\# A11039), and goat-anti-mouse CY5 conjugated IgG (Invitrogen-Cat\# A10524).

Verification of GR knockdown for functional PL-PFC knockdown study (AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40) was completed via immunohistochemical analysis of GR protein ([Figure 3C--D](#fig3){ref-type="fig"}). Sections (35 µm, series of 6) were processed as stated above before immunohistochemistry. The sections were processed as follows: incubated with 1% sodium borohydride/0.1M PBS for 30 min, rinsed 6 × 5 min in 0.1M PBS, incubated with 1% hydrogen peroxide/0.1M PBS for 10 min, rinsed 6 × 5 min in 0.1M PBS, rinsed additionally in 0.1M PBS 4 × 15 min. Sections were blocked by incubation with 0.1M PBS containing 4% goat serum with 0.4% Triton X-100% and 0.2% BSA for 2 hr, followed by incubation with rabbit polyclonal GR antibody (Invitrogen-Cat\# PA-521341) diluted 1:500 \[and no GFP antibody label (native virus expression)\] in blocking solution overnight at room temperature. After overnight antibody incubation, sections were rinsed in 0.1M PBS 3 × 5 min, then incubated in a cocktail of goat-anti-mouse CY3 conjugated IgG (Invitrogen-Cat\#A32727) diluted 1:800 in 0.1M PBS for 45 min, and rinsed 4 × 5 min in 0.1M PBS. All sections were mounted and viewed on a Nikon C2 Plus Confocal Microscope.

The validation of the GR knockdown was performed by obtaining relative intensity of GR expressing cells in both control and knockdown rats within and outside viral infected cells. This was performed in a semi quantitative manner (non-calibrated to known GR concentration). We used a partially automatized analysis in which the software (ImageJ software -U. S. National Institutes of Health, Bethesda, Maryland, USA) defines a level of background intensity in which GR/GFP is considered positive, and positive nuclei are outlined based on circularity and size which were previously manually validated. Specifically, the total number of GFP expressing cells (virus infected cells) in the PL-PFC was determined on the green channel. Using the outline of the GFP cells, a region of interest (GFP-ROI) was created (see representative image, [Figure 3](#fig3){ref-type="fig"}). On the red channel (GR), the total number of GR expressing cells was selected and the mean optical density (OD) was obtained (Total GR OD). This reflects the total intensity of GR staining in each image. Subsequently, the GFP-ROI was overlaid on to the red channel image to obtain the uncalibrated OD inside the GFP-ROI, corresponding to GR expression within virus infected cells. Note that subtraction of background optical density was not performed.

Verification of virus placement for the functional PL-PFC GR knockdown study (AAV9.CamKII.HI.eGFP-Cre.WPRE.SV40) was completed by immunohistochemical analysis of Cre recombinase protein ([Figure 3E](#fig3){ref-type="fig"}). Sections (series of 6) were processed as stated above before immunohistochemistry. Sections were washed 5 × 5 in 0.1M PBS and blocked in 0.2%BSA +0.4% Triton-X 100 + 4% goat serum. Sections were then incubated overnight in block at 4°C in monoclonal mouse cre recombinase antibody (Millipore-Cat\# MAB 3120) diluted 1:1000. The following day sections were washed 5 × 5 in 0.1M PBS and incubated in goat-anti-mouse CY3 conjugated IgG (Invitrogen A32727) diluted 1:500 at room temperature for 1 hr. All sections were mounted and viewed on a Nikon C2 Plus Confocal Microscope.

Auditory fear conditioning {#s4-6}
--------------------------

We used the ([@bib31]) method for auditory fear conditioning. Rats were placed into sound attenuated chambers (Med Associates Fairfax VT) with a 33×28×25 cm interior chamber within a 63×45×58 cm sound attenuating outer box and aluminum walls and aluminum rod floor. The fear conditioning paradigm was controlled by Ethovision software (Noldus Information Technology) and consisted of 3 days. On day one, (acquisition) rats were allowed to habituate to the chamber for 5 min followed by 5 x 30 s tones paired with shock, 0.5mA for 0.5 s, administered with 3 min inter-trial intervals (ITI). Rats were removed to their homecage and returned to the chamber 24 hr later. For day two (extinction), after another 5 min habituation, 20 x 30 s tones, with 3 min ITIs, were played with no shock at termination. Rats were again returned to the homecage for 24 hr. The last day, day three (extinction recall), consisted again of a 5 min habituation and 20 x 30 s tones, with 3 min ITIs. Freezing, the complete cessation of all movement other than respiration was measured by Freezescan software (CleverSys, Inc) during the 30 s tones.

Forced swim test (FST) {#s4-7}
----------------------

The FST was conducted in regular lighting 1--4 hr after the beginning of the light cycle. On day 1, rats were placed in a Plexiglas cylinder measuring 61 cm deep with a 19 cm diameter filled to 40 cm with tap water at 24--26°C for 10 min. On day 2, rats were again placed in the apparatus under the same conditions for 10 min. Sessions were video-recorded and behavior was later analyzed by recording whether the rat was swimming, climbing, diving, or immobile using Kinoscope software ([@bib20]) by an experimenter blind to genotype.

Corticosterone measurements after acute restraint {#s4-8}
-------------------------------------------------

Rats were restrained in a well ventilated plastic restrainer for 30 min. Blood samples were collected in EDTA containing microtubes via tail nick (well below the last vertebrae) with a sterile razor blade. Blood samples were taken at the following time points: 0 min -- basal before restraint, 15 min and 30 min while in the restrainer, and 60 min and 120 min after being released back into the home cage. Blood was kept on ice through the restraint and then centrifuged to remove plasma. Plasma was kept at −20°C until processed with a I-125 radioimmunoassay (RIA) kit from MP Biomedicals. Duplicates were run for each sample for technical replication.

Statistical analysis {#s4-9}
--------------------

Data are expressed as mean ± standard error of the mean (SEM). An unpaired t-test was used to analyze GR knockdown in females and males. A two-way repeated measures analysis of variance (ANOVA) was used to analyze fear conditioning data (parametric) and a general linear model was used for analysis of corticosterone data (non-parametric). Bonferroni was used for post hoc analyses when interactions were significant and also for a priori planned comparisons between genotypes. No data points were excluded as outliers. There were eight data points excluded on female fear conditioning for extinction recall due to software technical error. The forced swim testFST was analyzed using Student's two-tailed T-test. Behavioral data was scored by a researcher blinded to GRKD condition. Sigmaplot 13.0 (Systat Software) was used to analyze the data. GraphPad Prism 8 (San Diego, CA) and Sigmaplot 13.0 (Systat Software) was used to graphical present the data. For behavioral experiments, sample size was dependent on the outcome of breeding. Target 'n' was 10/group, based on previous power analyses performed in our group; however, 'n's were decreased due to missed or ineffective viral injections in the GRKD groups. Effect sizes were calculated to assess the strength of our findings in the face of reduced 'n's'. Effect sizes were in the in the small to medium (pη2, ANOVA) and medium to large (Cohen's d, t-tests) range.
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The individual editing activity was validated in rat C6 glioma cell line by T7E1 assay, compared side-by-side with a control sgRNA targeting rat *ApoE*. Cells were transfected with individual sgRNAs ([Appendix 1---table 1](#app1table1){ref-type="table"} lists the sgRNAs tested) and cultured for two days. Cells were then harvested for DNA extraction and T7E1 assay. The editing activity was calculated as percentage of the cut band intensity over the total band intensity. The data were represented as relative fold change respective to the control ([Appendix 1---figure 1](#app1fig1){ref-type="fig"}).

10.7554/eLife.44672.009

###### List of sgRNA chosen to target exon 3 of the *Nr3c1* gene (glucocorticoid receptor) for insertion of LoxP sites.

  Target location   ID           sgRNA target sequence
  ----------------- ------------ -----------------------
  5\' to exon 3     sg-1         TAAGGTGAACAGTAAACTAC
                    sg-2         GGAAGGGAAAGGTCTAT
                    sg-3         GTCATTTGATAGCATGGCA
  3\' to exon 3     sg-4         GAGCAGCTTTATTTTGGA
                    sg-5         GATTTGCTGTGAGATCAATC
                    sg-6         GATCCAAAGGAAACTGT
  control           ApoE sgRNA   GGTAATCCCAGAAGCGGTTC

![Validation of sgRNA editing activity by the T7E1 assay in rat C6 glioma cells, compared side-by-side with *ApoE* sgRNA that was previously shown to work efficiently in rat zygotes.\
Data presented as relative fold change between the percentage of cut band intensity over total band intensity induced by the individual sgRNAs and that of the control ApoE sgRNA.](elife-44672-app1-fig1){#app1fig1}

Off-target sequences {#s9}
--------------------

Off-target sequences associated with each sgRNA that were used to design the SD:nr3c1^fl/fl^ rat were carefully considered ([Appendix 1---table 2](#app1table2){ref-type="table"}). The required primers ([Supplementary file 1](#supp1){ref-type="supplementary-material"}) were designed with Primer3 software Web for the sequences with highest off-target score, based on the CRISPOR Webtool (<http://crispor.tefor.net>). PCR products were purified with Thermo Scientific GeneJET Gel Extraction Kit and sequenced by the DNA Sequencing Core at Cincinnati Children's Hospital Medical Center. We performed off-target analysis on the generated chromatograms by comparing peak-to-peak and nucleotide-to-nucleotide signatures between SD:nr3c1^wt^ and SD:nr3c1^fl/fl^ rats. We observed no off-target events among the most likely off-target sites ([Appendix 1---table 2](#app1table2){ref-type="table"}).

10.7554/eLife.44672.011

###### List of off-target sequences used to identify the off-target events.

  Off-target sequences                                                                                                                                         
  ---------------------- -------------------------- -------------------------- --------------------------- -------- ------------------------------------------ ----------------
  OT-1                   TCTGGAAGGGAAAGGTCTAT AGG   TTGAGAACGGAAAGGTCTAT GGG   chr19:18822843--18822865    \-       intergenic:AABR07043040.1-AABR07043071.1   0
  OT-2                   TCTGGAAGGGAAAGGTCTAT AGG   TTGAGAACGGAAAGGTCTAT GGG   chr19:18815538--18815560    \-       intergenic:AABR07043039.1-AABR07043040.1   0
  OT-3                   TCTGGAAGGGAAAGGTCTAT AGG   GTAAGAAGGGAAAGGTCTAT GGG   chr7:13815358--13815380     \+       intergenic:Slc1a6-Cyp4f37                  0
  OT-4                   TCTGGAAGGGAAAGGTCTAT AGG   TATGCAGAGGAAAGGTCTAT TGG   chr3:171628668--171628690   \+       intergenic:LOC689618-Rab22a                0
  OT-5                   TCTGGAAGGGAAAGGTCTAT AGG   TAAGCAAGTGAAAGGTCTAT AGG   chr4:25084248--25084270     \+       intergenic:U1-Steap1                       0
  OT-6                   TCTGGAAGGGAAAGGTCTAT AGG   GCAGTAAGGGGAAGGTCTAT GGG   chr6:38673626--38673648     \+       intron:Nbas                                0
  OT-7                   TCTGGAAGGGAAAGGTCTAT AGG   ACAGGAAGGATAAGGTCTAT TGG   chr15:91803840--91803862    \+       intergenic:AABR07019155.1-AABR07019162.1   0
                         3\' guide sequence         off-target sequence        Location                    strand   locus description                          mismatch found
  OT-8                   AGAGATCCAAAGGAAACTGT GGG   AATTCTCCAAAGGAAACTGT GGG   chr14: 46180580--46180602   \-       intergenic:Nwd2-AABR07015040.1             0
  OT-9                   AGAGATCCAAAGGAAACTGT GGG   GGAAATGCACAGGAAACTGT GGG   chr13:47968158--47968180    \-       intron:Rassf5                              0
  OT-10                  AGAGATCCAAAGGAAACTGT GGG   ACACAGCGAAAGGAAACTGT GGG   chr7:101131361--101131383   \-       intron:LOC500877                           0
  OT-11                  AGAGATCCAAAGGAAACTGT GGG   ATGAATCCTAAGGAAACTGT AGG   chr2:189985378--189985400   \-       intergenic:U1/S100a3-S100a3                0
  OT-12                  AGAGATCCAAAGGAAACTGT GGG   TGAGCTCCTGAGGAAACTGT AGG   chr11:75363850--75363872    \+       intergenic:Hrasls-Mb21d2                   0

Copy number analysis {#s10}
--------------------

DNA was extracted from brain samples of two SD:nr3c1^wt^ (WT) and two SD:nr3c1^fl/fl^ (f/f) rats by Purelink genomic DNA extraction kit (ThermoFisher, Cat\# K1820-01). qPCR was performed in triplicates using primers ordered from IDT and Power SYBR Green PCR Master Mix (ThermoFisher, Cat\#: 4367659) with QuantStudio 7 Pro Real-Time PCR Systems. 18 ng/ul gDNA from each sample was used for each reaction. Following the quantifying cycles, the melt curve analysis was performed for each reaction to make sure there was a single product. The copy number was determined by the double delta Ct analysis. The delta Ct value from each region of the WT samples was set as two copies per genome ([Appendix 1---figure 2](#app1fig2){ref-type="fig"}).

![Screen for random integration of the donor plasmid in homozygous *Nr3c1* floxed rats.\
(**A**) SYBR Green-based qPCR was used to determine the copy number of the transgene in rats. Three regions of the integrated area were chosen for the analysis (Set A, Set B, and Set C). A region outside of the integrated area was used as an internal reference (Set D). Data presented as relative copy number of each region between the SD:nr3c1^wt ^(WT) and SD:nr3c1^fl/fl ^(f/f) samples. The delta Ct value of the WT sample as set as two copies per genome. (**B**) PCR amplifying two distant regions of the donor plasmid backbone was performed to detect the random integration event. A limited amount of the donor plasmid DNA was spiked into the WT genomic DNA as positive control.](elife-44672-app1-fig2){#app1fig2}

Behavioral characterization {#s11}
---------------------------

GR floxed Heterozygotes from the NF2 generation were bred together producing three genotypes, SD:nr3c1^fl/fl^ (f/f), SD:nr3c1^fl/-^ (het), and SD:nr3c1^wt^ (wt). Only f/f and wt littermate controls were used for behavioral and physiological measures. All litters were born within 4 days of one another and were 8 weeks of age at the beginning of behavioral assays. Rats were single housed during behavioral experiments in a temperature and humidity controlled vivarium on a 12/12 hr light cycle with ad libitum access to food and water. (n = 12 female f/f and n = 12 female wt; n = 12 male f/f and n=12 male wt).

Elevated plus maze (EPM) and Open field (OF) tests were performed in dim light 1--4 hr after the beginning of the light cycle. For the EPM, rats were placed on an elevated plus maze with two closed arms ipsilateral from one another and two ipsilateral open arms. Arms measured 10 cm x 50 cm and were elevated 62 cm from the ground. Rats were allowed to freely explore the maze for 5 min where time spent in open arms and closed arms was analyzed by Ethovision software (Noldus Information Technology, Wageningen - The Netherlands). For the OF, rats were placed in an uncovered plastic square arena measuring 92 cm × 92 cm and allowed to explore freely for 5 min. The number of entries into a square center area measuring 45 cm x 45 cm was analyzed, along with total locomotion, by Ethovision software (Noldus Information Technology, Wageningen - The Netherlands). Animals also underwent the forced swim test (FST) as described in the main text.

The EPM is a common test for anxiety like behavior. Time spent exploring open arms is considered as less anxious, while more anxious animals tend to stay in closed arms where there are less environmental threats. Male and female rats from f/f or wt groups all spend equal amounts of time exploring open arms \[Male T(20) = −1.207; p=0.241 ([Appendix 1---figure 3A](#app1fig3){ref-type="fig"}); Female T(19) = −0.0939; p=0.926 ([Appendix 1---figure 3B](#app1fig3){ref-type="fig"})\].

![SD:nr3c1^fl/fl^ (f/f) rats did not show behavioral differences from SD:nr3c1^wt^ (wt) controls in common behavioral assays.\
Male (**A**) and female (**B**) f/f and wt controls spent equal time in the open arms of the elevated plus maze. Males (**C**) and females (**D**) showed no differences in time spent in the center of the open field. No locomotor phenotype was observed in male (**E**) and female (**F**) f/f rats compared to wt controls in the open field. There were no differences in immobility in the forced swim test for male (**G**) or female (**H**) f/f rats compared to controls.](elife-44672-app1-fig3){#app1fig3}

Similarly, the OF is a test for anxious behavior with anxious rats spending the majority of the 5 min OF test around the periphery where the rodent feels less exposed to environmental dangers. Less anxious rats will explore the center of the arena more. Any alterations to locomotion in animal models can also be seen in the OF test. When tested in the OF, GR floxed rats explored the center for the same amount of time as wt controls in both males \[T(20)=0.762; p=0.455 ([Appendix 1---figure 3C](#app1fig3){ref-type="fig"}\] and females \[T(19)=−1.563; p=0.134 ([Appendix 1---figure 3D](#app1fig3){ref-type="fig"})\]. The f/f male rats and wt male rats showed no differences in locomotion in the maze \[T(20)=1.365; p=0.187 ([Appendix 1---figure 3E](#app1fig3){ref-type="fig"})\], and the same was true for the female f/f and female wt rats \[T(19)=−0.0326; p = 0.974 [Appendix 1---figure 3F](#app1fig3){ref-type="fig"}\].

In studies focusing on the effects of stress, the FST is often used as an assay to test for the efficacy of antidepressants to attenuate phenotypes ([@bib8]). Antidepressants have been shown to decrease immobility, considered passive coping behavior. Further the FST tests for the rodents coping mechanism and how that can change after a manipulation such as chronic stress ([@bib24]; [@bib13]). There were no differences in FST immobility for male \[T(20)=1.960; p=0.0641 ([Appendix 1---figure 3G](#app1fig3){ref-type="fig"})\] nor female f/f and wt rats \[T(19)=1.178; p=0.253 ([Appendix 1---figure 3H](#app1fig3){ref-type="fig"})\].

Physiology measures {#s12}
-------------------

To verify that the gene editing protocol had no effect on peripheral physiology, animals were weighed either weekly or bi-weekly from weaning, and heart, thymus, and adrenals were dissected from animals after euthanasia (rapid decapitation) and weighed. No differences were observed in body weight profiles in either male ([Appendix 1---figure 4A](#app1fig4){ref-type="fig"}) or female ([Appendix 1---figure 4B](#app1fig4){ref-type="fig"}) SD:nr3c1^fl/fl^ relative to SD:nr3c1^wt^ controls. Similarly, weight of peripheral organs (thymus, adrenals, heart) were not affected by gene targeting ([Appendix 1---table 3](#app1table3){ref-type="table"}).

![SD:nr3c1^fl/fl^ (f/f) rats did not differ in bodyweight compared to SD:nr3c1^wt^ (wt) controls.\
Male (**A**) and female (**B**) fl/fl and wt rats did not differ in weight at weening (w) or over the course of the experiment.](elife-44672-app1-fig4){#app1fig4}

10.7554/eLife.44672.015

###### Hearts, thymi, and adrenal weights did not differ in fl/fl vs. wt controls.

  Males               Organ     Wt weight (mg)   St error   F/f Weight (g)   St error           T-test             P value
  ------------------- --------- ---------------- ---------- ---------------- ------------------ ------------------ ---------
                      Heart     1284.762         37.318     1272.990         21.168             T~(20) ~= 0.286    p=0.778
  Thymus              302.546   15.669           272.880    16.244           T~(20) ~= 1.299    p=0.209            
  Adrenals Averaged   28.188    0.565            29.050     1.266            T~(20) ~= −0.581   p=0.568            
  Females             Organ     wt Weight (mg)   St Error   f/f Weight (g)   St Error           T-test             P value
                      Heart     805.408          60.710     835.467          16.912             T~(19) ~= −0.417   p=0.681
  Thymus              211.383   13.307           230.733    9.894            T~(19) ~= −1.097   p=0.287            
  Adrenals Averaged   45.100    2.113            42.633     1.007            T~(19) ~= 0.947    p=0.355            

Statistical analysis {#s13}
--------------------

Data are expressed as mean ± standard error of the mean (SEM). Student's two-tailed T-test was used to analyze behavioral data (EPM, OF and FST) and organ weights. Body weight was analyzed by two-way repeated measures ANOVA. No data points were excluded as outliers. Behavioral data was scored by a researcher blinded to condition on Ethovision software (Noldus Information Technology, Wageningen - The Netherlands). Sigmaplot 13.0 (Systat Software) was used to analyze the data and for graphical representation of the data. For behavioral experiments, sample size was dependent on the outcome of breeding. Target 'n' was 10/group, based on previous power analyses performed in our group.

10.7554/eLife.44672.017
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Thank you for submitting your article \"Use of CRISPR/Cas9 gene targeting to conditionally delete glucocorticoid receptors in rat brain\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Geoffrey Schoenbaum as the Reviewing Editor and Catherine Dulac as the Senior Editor. The following individuals involved in review of your submission have also agreed to reveal their identity: Brandon K Harvey (Reviewer \#1) and Carmen Sandi (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In the current study, the authors report the development of a conditional deletion of the GR in rats. They provide credible evidence that their tool works, affects GR conditionally and that this impacts behavior as expected. The reviewers agreed that having such a tool available in rats would be a substantial step forward for the field. There are concerns but they are requests for details or changes in emphasis, none of which should take more than a few months. If the paper is revised with the additional details, the reviewers agreed that it would be acceptable for publication.

Essential revisions:

The essential revisions are targeted at providing additional detail that was thought to be critical to the validity of the tool. Other details requested in the reviews are important, but these are particularly critical as they support the rationale for publishing. There are three:

1\) Correcting the emphasis on CRISPR as raised by reviewer 1.

2\) Immunostaining patterns comparing effects in males and females as raised by reviewer 2.

3\) Sequencing of PCR amplicons for the entire integrated transgene as raised by reviewer 1.

*Reviewer \#1:*

The authors have developed a conditional knockout rat based on the Cre-loxP system to remove exon 3 of the Nr3c1 gene encoding the glucocorticoid receptor. They employ CRISPR/Cas9 in the development of a conditional knockout rat for the Nr3c1 gene. There is an overemphasis on the use of CRISPR/Cas9 starting with the title which is misleading in its current form. The conditional deletion of GR in rat brain is conditional on Cre not Cas9. Additionally, there is no evidence that CRISPR was required to make the animal. They obtained 1 animal out of 60 with the transgene. This could occur by injecting the targeting plasmid (as was done prior to the now common use of CRISPR for increased targeting). It is likely CRISPR aided in the process but there is no evidence for this (e.g. a plasmid alone was not injected and for good reason). The authors also do no appear to have done any PCR/Sequence/T7 assay/TIDE analysis on any of the 59 negative animals for evidence of CRISPR-induced mutation (which may have provided some possibly interesting GR mutants but this was not the goal). CRISPR should be deemphasized and focus on the fact there is a new Cre-dependent KO for GR and some possibly interesting biological observations using this new resource.

The authors claim in the first paragraph of the Results section that offspring fecundity is evidence of no random integration. This is not the case. There may be random integration that doesn\'t affect breeding but disrupts other gene function. A copy number per genome determination is needed. A PCR assay internal to the transgene that uses one of the primers partially overlapping the loxP site to avoid amplification of endogenous locus and a PCR assay to a single copy gene in the genome (2 copies per genome) should be used for QPCR to determine transgene copy number per genome. This assay is becoming a standard practice in transgenic animal development. Also, if the entire plasmid was injected, PCR assays designed to detect other plasmid segments is recommended.

The authors do not appear to have sequenced PCR amplicons for the entire integrated transgene. This is important to show no mutations or aberrant repair occurred at the single nucleotide level. Years of work may be built on these animals that have a point mutation in exon 3 altering function of GR. Alignment of sequencing data to in silico predicted sequence should be provided as supplement.

The use pf AAVrg-CAG-GFP as control for AAVrg pmSyn1-EBFP-Cre is not clear. These are different promoters and transgenes (e.g. using a \"dead\" Cre in the same construct would be preferred). Consistent with other experiments, AAVrg pmSyn1-EBFP-Cre should be injected into WT animals as control.

Overall, the finding of GR knockout in the prelimbic area affecting behavior is mostly confirmatory with published work while providing some interesting phenomenological observations for future studies. As such, this is a methods paper describing a transgenic rat with much potential and may be better in a specialized journal or methods section of neuroscience journal.

*Reviewer \#2:*

Scheimann et al. generated a conditional GR knockout in rats using CRISPR/Cas9 technology. They provide evidence of targeted GR deletion in specific cell types, brain regions, and circuits via viral vector-mediated delivery of Cre. They also report that deletion of GR in output neurons of the prelimbic cortex resulted in sex-specific deficits in extinction of conditioned fear in females and a shift to active coping in the forced swim test in males. The manuscript is well-written and development of a conditional GR knockout model in rat is important and will be useful tool for probing GR function in the brain. However, there are several major limitations to the data that should be addressed to strengthen the conclusions of the manuscript.

1\) Given the sex-specific effects on behavior, it is critical to show and evaluate the immunostaining patterns from both male and female rats. Are sex-specific differences observed in the distribution, efficiency, and/or extent of GR knockout in male and female brains?

2\) Does the loss of GR lead to compensatory increases in the expression of the related receptor MR? This is an important consideration given that MR binds corticosterone, is co-expressed with GR in many brain regions, and is known to play a role in stress and emotional behavior.

3\) Several issues should be addressed concerning Figure 2:

a\) Why is the immunostaining pattern for GR in panel C different than in panel A? For the GR knockout cells in panel C, it appears that GR immunostaining is lost in the nucleus but not the cytoplasm. Why is this the case?

b\) The authors use AAVrg-CAG-GFP injection of SD:nr3c1fl/fl rats as a control for the AAVrg pmSyn1-EBFP-Cre injection (panels E and F). Another important control is injection of AAVrg pmSyn1-EBFP-Cre into wild-type rats. Was this control performed?

c\) The images should be enlarged. The small size of the images makes it very difficult to evaluate the staining patterns.

4\) Does knockout of GR in the prelimbic cortex alter locomotor activity of the rats?

5\) The sample size for the GR knockout rats is quite small (n = 5 for females and n = 6 for males) for behavioral studies. In addition, a Fisher\'s LSD test was employed for post-hoc analyses. Are similar significance results found when statistical tests are utilized that correct for multiple comparisons?

*Reviewer \#3:*

This is the first study that develops a rat model with the capacity to perform cell- and region-specific deletion of the glucocorticoid receptor (GR) in rats. In addition to the novel tool development, the authors provided evidence of the behavioral impact of specific deletion of GR in the rat prelimbic CamKII-(glutamatergic) containing neurons. The data indicates differential effects of the knockdown approach on fear conditioning and extinction and behavior in the forced swim test in males and females, with a minor effect on corticosterone recovery in females. The study seems to be well performed and it is clearly written. Rats as model organisms have proved superior to mice for the dissection of stress (neuro)physiology and behavior and the current resource is a major step forward for the interrogation of GR function in this animal species.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Conditional deletion of glucocorticoid receptors in Rat brain results in sex specific deficits in fear&coping behaviors\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Catherine Dulac (Senior Editor), a Reviewing Editor, and two reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

Please remove the statement concerning reviewer 1 below, and make certain the second issue raised is clearly noted as a caveat of the study if more data cannot be provided to address this directly.

*Reviewer \#1:*

Below in quotes are the authors\' responses to previous concerns. A follow up response is given. All other concerns were adequately addressed.

Authors: \"...addition, we would like to clarify that we described the fact \"the offspring of rat \#60 can be bred to homozygosity indicates the correct targeting of loxP sequences to the Nr3c1 gene, instead of random integration\". We did not mention anywhere in the text that offspring fecundity is evidence of no random integration.\"

My response: Although it is true the authors don\'t use the same verbiage, the ability to produce homozygous offspring should not be used as an indicator of correct targeting. The integration could still have additional integrants which would likely would be outcrossed if on a different chromosome or at least a sufficient distance from the targeted allele being genotyped. However, the only way to verify is to assay for such events and the authors have now done a more rigorous analysis to characterize the transgene integration. The statement in quotes provides an unnecessary precedent and contributes to the propagation of inadequate characterization of novel transgenic animals. It is not needed especially with the additional data and should be revised as simple statement of fact without indication or just remove it.

Authors: \"The authors acknowledge that the use of these 2 viruses may not be entirely clear. The viruses used for these experiments were sourced from Addgene. At the time these experiments were performed, this combination of \"control\" and \"Cre\" viruses were the best available. The AAVrg pmSyn1-EBFP-Cre virus was not available in a non-Cre construct nor was the AAVrg-CAG-GFP virus available with a Cre insert. Addgene has now updated its inventory and the AAVrg pmSyn1-EBFP-Cre is no longer available and so we are unable to perform surgeries in WT animals at this time as suggested by the reviewers.\"

My response: Given that GFP expression has been demonstrated to cause toxicity, the concern is that any differences observed may be due to differences in viral transgene expression. Do AAVrg-CAG-GFP injected animals have same behavior as uninjected animals? At minimum, a strong emphasis must be placed on this caveat of the study. This is the only major concern remaining.

*Reviewer \#3:*

The authors have addressed all my previous points satisfactorily. I do not have any further issues. The paper represents an important addition and tool to the field.

10.7554/eLife.44672.018

Author response

> Essential revisions:
>
> The essential revisions are targeted at providing additional detail that was thought to be critical to the validity of the tool. Other details requested in the reviews are important, but these are particularly critical as they support the rationale for publishing. There are three:
>
> 1\) Correcting the emphasis on CRISPR as raised by reviewer 1.
>
> 2\) Immunostaining patterns comparing effects in males and females as raised by reviewer 2.
>
> 3\) Sequencing of PCR amplicons for the entire integrated transgene as raised by reviewer 1.

Reviewer \#1:

> The authors have developed a conditional knockout rat based on the Cre-loxP system to remove exon 3 of the Nr3c1 gene encoding the glucocorticoid receptor. They employ CRISPR/Cas9 in the development of a conditional knockout rat for the Nr3c1 gene. There is an overemphasis on the use of CRISPR/Cas9 starting with the title which is misleading in its current form. The conditional deletion of GR in rat brain is conditional on Cre not Cas9. Additionally, there is no evidence that CRISPR was required to make the animal. They obtained 1 animal out of 60 with the transgene. This could occur by injecting the targeting plasmid (as was done prior to the now common use of CRISPR for increased targeting). It is likely CRISPR aided in the process but there is no evidence for this (e.g. a plasmid alone was not injected and for good reason). The authors also do no appear to have done any PCR/Sequence/T7 assay/TIDE analysis on any of the 59 negative animals for evidence of CRISPR-induced mutation (which may have provided some possibly interesting GR mutants but this was not the goal). CRISPR should be deemphasized and focus on the fact there is a new Cre-dependent KO for GR and some possibly interesting biological observations using this new resource.

We appreciate the reviewer's comments and have now changed the title to more accurately describe the content of the paper. We also wanted to clarify that in the first paragraph of the Results section, we described that we obtained 1 *Nr3c1* floxed animal out of 17 pups, as a result of microinjection of 60 fertilized eggs. This *Nr3c1* floxed animal was \#60, which may have caused the viewer to think that 1 correctly targeted animal was obtained from 60. Therefore, we changed \#60 to No. \#60 in the text. In addition, the rest of 16 negative animals carried the alleles, including single loxP, large deletion between two sgRNA target sites, and indels at individual sgRNA target sites. As also mentioned by the reviewer, it was not our goal to study animals with a partially integrated transgene, indels at introns or knockout alleles (which is lethal) for the current study. Therefore, we do not show the genotyping data for the 16 negative animals in the manuscript.

> The authors claim in the first paragraph of the Results section that offspring fecundity is evidence of no random integration. This is not the case. There may be random integration that doesn\'t affect breeding but disrupts other gene function. A copy number per genome determination is needed. A PCR assay internal to the transgene that uses one of the primers partially overlapping the loxP site to avoid amplification of endogenous locus and a PCR assay to a single copy gene in the genome (2 copies per genome) should be used for QPCR to determine transgene copy number per genome. This assay is becoming a standard practice in transgenic animal development. Also, if the entire plasmid was injected, PCR assays designed to detect other plasmid segments is recommended.

We fully agree with the reviewer's comments and have presented the data showing the evidence of no random integration. We included two additional experiments in the revision. First, we performed a copy number analysis on three regions of the integrated area, including '5 to 5' loxP, 3' to 3' loxP and between two loxP sites. We compared two WT and two homozygous *Nrc31* floxed rats and confirmed that there are 2 copies per genome for each of the three regions examined (Appendix 1---figure 2). Secondly, because a circular DNA plasmid was used for microinjection to reduce the random integration, we performed the PCR using the primers encompassing the either end of the plasmid backbone sequence. Both reactions did not detect any signals (Appendix 1---figure 2), consistent with the copy analysis indicating the absence of random integration. In addition, we would like to clarify that we described the fact "the offspring of rat \#60 can be bred to homozygosity indicates the correct targeting of loxP sequences to the *Nr3c1* gene, instead of random integration". We did not mention anywhere in the text that offspring fecundity is evidence of no random integration.

> The authors do not appear to have sequenced PCR amplicons for the entire integrated transgene. This is important to show no mutations or aberrant repair occurred at the single nucleotide level. Years of work may be built on these animals that have a point mutation in exon 3 altering function of GR. Alignment of sequencing data to in silico predicted sequence should be provided as supplement.

We appreciate the reviewer's suggestion. We have performed the long-range PCR using the primers encompassing the entire transgene region and sequenced from end to end. We confirmed that the DNA from two homozygous *Nr3c1* floxed animals showed no mutation in and near the coding sequence. However, we detected an A/T base change at chr18:31,744,353, compared to the rn6 reference genome, which is located in a non-conserved intronic region next to a SINE transposable element. Given that SD rats are an outbred strain and the location of the base change, we do not expect that this particular base difference will cause any significant effect. We have documented it in the revision (Results paragraph one).

> The use pf AAVrg-CAG-GFP as control for AAVrg pmSyn1-EBFP-Cre is not clear. These are different promoters and transgenes (e.g. using a \"dead\" Cre in the same construct would be preferred). Consistent with other experiments, AAVrg pmSyn1-EBFP-Cre should be injected into WT animals as control.

The authors acknowledge that the use of these 2 viruses may not be entirely clear. The viruses used for these experiments were sourced from Addgene. At the time these experiments were performed, this combination of "control" and "Cre" viruses were the best available. The AAVrg pmSyn1-EBFP-Cre virus was not available in a non-Cre construct nor was the AAVrg-CAG-GFP virus available with a Cre insert. Addgene has now updated its inventory and the AAVrg pmSyn1-EBFP-Cre is no longer available and so we are unable to perform surgeries in WT animals at this time as suggested by the reviewers.

> Overall, the finding of GR knockout in the prelimbic area affecting behavior is mostly confirmatory with published work while providing some interesting phenomenological observations for future studies. As such, this is a methods paper describing a transgenic rat with much potential and may be better in a specialized journal or methods section of neuroscience journal.

The conditional knockout of GR specifically in the CaMKIIα positive neurons in the prelimbic cortex, as opposed to the entire mPFC, is novel and has not been described elsewhere. The reviewer is correct in that, our lab and others have previously shown behavioral and hormonal consequences of mPFC GR knockdown; however, these studies did not include females, nor did they have a specific promotor driven knockdown (meaning all neurons were affected unlike our CAMKIIα selective neuronal population). Additionally, we and others have also employed Cre-Driver lines to knockout GR but these genetic models are confounded by the developmental and peripheral functions of GR. We believe the current dataset is a more targeted approach in terms of cellular specificity, brain region targeted and time constrained and adds to the growing body of literature. Further, to our knowledge, differences in diving behavior have not been published after GRKD manipulations.

Reviewer \#2:

> Scheimann et al. generated a conditional GR knockout in rats using CRISPR/Cas9 technology. They provide evidence of targeted GR deletion in specific cell types, brain regions, and circuits via viral vector-mediated delivery of Cre. They also report that deletion of GR in output neurons of the prelimbic cortex resulted in sex-specific deficits in extinction of conditioned fear in females and a shift to active coping in the forced swim test in males. The manuscript is well-written and development of a conditional GR knockout model in rat is important and will be useful tool for probing GR function in the brain. However, there are several major limitations to the data that should be addressed to strengthen the conclusions of the manuscript.

The authors appreciate this positive feedback and have addressed the specific concerns below.

> 1\) Given the sex-specific effects on behavior, it is critical to show and evaluate the immunostaining patterns from both male and female rats. Are sex-specific differences observed in the distribution, efficiency, and/or extent of GR knockout in male and female brains?

These additional experiments have now been performed and added to the paper (Results subsection "Behavioral Consequences of Targeted GR Deletion; Implications for Fear and Coping Behaviors"; Figure 3; Materials and methods paragraph three of subsection "Immunohistochemistry"). We found significant knockdown in both females and males and no overt sex differences between groups.

> 2\) Does the loss of GR lead to compensatory increases in the expression of the related receptor MR? This is an important consideration given that MR binds corticosterone, is co-expressed with GR in many brain regions, and is known to play a role in stress and emotional behavior.

We did not assess MR expression in the current study and although MR and GR both bind corticosterone we are particularly interested in the role of GR as it plays a stronger role in the "stress corticosterone state" and subsequent behavioral consequences such as fear and coping strategies. Although MR and GR are somewhat similar we do not believe that MR acts in a direct compensatory capacity in response to GR knockout. This is beyond the scope of the current work but may be addressed in future studies.

> 3\) Several issues should be addressed concerning Figure 2:
>
> a\) Why is the immunostaining pattern for GR in panel C different than in panel A? For the GR knockout cells in panel C, it appears that GR immunostaining is lost in the nucleus but not the cytoplasm. Why is this the case?

The immunostaining patterns appear different as 2 different GR antibodies were used. Panels A,B, E, F were all performed using a Santa Cruz (sc 1004) GR antibody prior to it being discontinued. Panels C and D were performed using an Invitrogen (PA1-511A) GR antibody. Both antibodies were rabbit polyclonal however they are not identical and thus have different immunostaining patterns.

> b\) The authors use AAVrg-CAG-GFP injection of SD:nr3c1fl/fl rats as a control for the AAVrg pmSyn1-EBFP-Cre injection (panels E and F). Another important control is injection of AAVrg pmSyn1-EBFP-Cre into wild-type rats. Was this control performed?

Addressed previously in response to reviewer \#1.

"The authors acknowledge that the use of these 2 viruses may not be entirely clear. The viruses used for these experiments were sourced from Addgene. At the time these experiments were performed, this combination of "control" and "Cre" viruses were the best available. The AAVrg pmSyn1-EBFP-Cre virus was not available in a non-Cre construct nor was the AAVrg-CAG-GFP virus available with a Cre insert. Addgene has now updated its inventory and the AAVrg pmSyn1-EBFP-Cre is no longer available and so we are unable to perform surgeries in WT animals at this time as suggested by the reviewers."

> c\) The images should be enlarged. The small size of the images makes it very difficult to evaluate the staining patterns.

All figures have now been uploaded as a separate files for clearer visualization.

> 4\) Does knockout of GR in the prelimbic cortex alter locomotor activity of the rats?

We did not perform a separate measure of locomotion, such as the open field, in the current study.

> 5\) The sample size for the GR knockout rats is quite small (n = 5 for females and n = 6 for males) for behavioral studies. In addition, a Fisher\'s LSD test was employed for post-hoc analyses. Are similar significance results found when statistical tests are utilized that correct for multiple comparisons?

We have re-ran our statistical analyses using Bonferroni post hoc to correct for multiple comparisons and found that all post hoc differences remain significant at p =/\<0.05.

Reviewer \#3:

> This is the first study that develops a rat model with the capacity to perform cell- and region-specific deletion of the glucocorticoid receptor (GR) in rats. In addition to the novel tool development, the authors provided evidence of the behavioral impact of specific deletion of GR in the rat prelimbic CamKII-(glutamatergic) containing neurons. The data indicates differential effects of the knockdown approach on fear conditioning and extinction and behavior in the forced swim test in males and females, with a minor effect on corticosterone recovery in females. The study seems to be well performed and it is clearly written. Rats as model organisms have proved superior to mice for the dissection of stress (neuro)physiology and behavior and the current resource is a major step forward for the interrogation of GR function in this animal species.

The authors appreciate this positive feedback.

> \[Editors\' note: further revisions were requested prior to acceptance, as described below.\]
>
> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> Please remove the statement concerning reviewer 1 below, and make certain the second issue raised is clearly noted as a caveat of the study if more data cannot be provided to address this directly.

Reviewer \#1:

> Below in quotes are the authors\' responses to previous concerns. A follow up response is given. All other concerns were adequately addressed.
>
> Authors: \"...addition, we would like to clarify that we described the fact \"the offspring of rat \#60 can be bred to homozygosity indicates the correct targeting of loxP sequences to the Nr3c1 gene, instead of random integration\". We did not mention anywhere in the text that offspring fecundity is evidence of no random integration.\"
>
> My response: Although it is true the authors don\'t use the same verbiage, the ability to produce homozygous offspring should not be used as an indicator of correct targeting. The integration could still have additional integrants which would likely would be outcrossed if on a different chromosome or at least a sufficient distance from the targeted allele being genotyped. However, the only way to verify is to assay for such events and the authors have now done a more rigorous analysis to characterize the transgene integration. The statement in quotes provides an unnecessary precedent and contributes to the propagation of inadequate characterization of novel transgenic animals. It is not needed especially with the additional data and should be revised as simple statement of fact without indication or just remove it.

We appreciate the reviewer's comment and have now changed the text accordingly to remove any indication. "We have consistently bred the offspring of rat \#60 to homozygosity (Figure 1G)."

> Authors: \"The authors acknowledge that the use of these 2 viruses may not be entirely clear. The viruses used for these experiments were sourced from Addgene. At the time these experiments were performed, this combination of \"control\" and \"Cre\" viruses were the best available. The AAVrg pmSyn1-EBFP-Cre virus was not available in a non-Cre construct nor was the AAVrg-CAG-GFP virus available with a Cre insert. Addgene has now updated its inventory and the AAVrg pmSyn1-EBFP-Cre is no longer available and so we are unable to perform surgeries in WT animals at this time as suggested by the reviewers.\"
>
> My response: Given that GFP expression has been demonstrated to cause toxicity, the concern is that any differences observed may be due to differences in viral transgene expression. Do AAVrg-CAG-GFP injected animals have same behavior as uninjected animals? At minimum, a strong emphasis must be placed on this caveat of the study. This is the only major concern remaining.

We appreciate the reviewer's comment and have now clearly acknowledged this caveat in the text (Results subsection "Validation of Conditional Gene Deletion: Viral Vector Targeting"). "Although we made every effort to employ appropriate viral controls, we were limited by the availability of viral constructs, specifically AAV retrograde constructs, and this is a caveat of the current study. For our intersectional approach we used the same AAV serotype (AAVrg) for both knockdown and controls however, the promoter (pmSyn1 vs CAG) and fluorescent reporter (EBFP vs GFP) were different. These constructs were chosen as the best available at the time of running the experiments."

These specific animals were used for immunohistochemical analysis only and were not used in any behavioral testing so we are unable to say at this time if the GFP-virus led to changes in behavior.

[^1]: These authors contributed equally to this work.
